News headlines about CareTrust REIT (NASDAQ:CTRE) have been trending positive on Tuesday, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. CareTrust REIT earned a media sentiment score of 0.28 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 33 out of 100, meaning that recent news coverage is unlikely to have an impact on the stock’s share price in the near future.
Here are some of the news articles that may have effected Accern’s analysis:
- Zacks Investment Research Upgrades CareTrust REIT, Inc. (NASDAQ:CTRE) to “Buy” (americanbankingnews.com)
- Brokerages Anticipate CareTrust REIT, Inc. (NASDAQ:CTRE) Will Announce Quarterly Sales of $31.59 Million (americanbankingnews.com)
- CareTrust REIT, Inc. (CTRE) Receives Consensus Rating of “Buy” from Brokerages (americanbankingnews.com)
- ETFs with exposure to CareTrust REIT, Inc. : July 14, 2017 (finance.yahoo.com)
- Hudson Bay Capital Issues Open Letter to Sabra Shareholders Urging Them to Vote against Proposed Acquisition of Care Capital (advfn.com)
CareTrust REIT (NASDAQ CTRE) opened at 18.23 on Tuesday. CareTrust REIT has a one year low of $12.70 and a one year high of $19.86.
The company also recently announced a quarterly dividend, which was paid on Friday, July 14th. Investors of record on Friday, June 30th were given a $0.185 dividend. The ex-dividend date was Wednesday, June 28th. This represents a $0.74 annualized dividend and a yield of 4.06%.
A number of brokerages have weighed in on CTRE. BidaskClub upgraded shares of CareTrust REIT from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 15th. Zacks Investment Research downgraded shares of CareTrust REIT from a “hold” rating to a “sell” rating in a research report on Tuesday, April 18th. BMO Capital Markets restated a “buy” rating and set a $16.00 price target on shares of CareTrust REIT in a research report on Monday, March 20th. Raymond James Financial, Inc. reaffirmed an “outperform” rating and set a $19.00 price objective (up previously from $17.00) on shares of CareTrust REIT in a research note on Wednesday, May 17th. Finally, TheStreet raised shares of CareTrust REIT from a “c” rating to a “b” rating in a research note on Friday, May 5th. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. CareTrust REIT currently has an average rating of “Buy” and a consensus target price of $18.00.
About CareTrust REIT
CareTrust REIT, Inc is a self-administered, self-managed real estate investment trust. The Company is engaged in the ownership, acquisition and leasing of healthcare-related properties. It makes investments in healthcare-related real estate assets. As of December 31, 2016, its real estate portfolio included 154 skilled nursing facilities (SNFs), SNF Campuses, assisted living facilities and independent living facilities.
Receive News & Ratings for CareTrust REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareTrust REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.